OppHub America Desk · · Source: yahoo-sector-etfs
Healthcare Stocks Climb Late; Eli Lilly, Charles River Rise
- Eli Lilly (LLY) gained 4.7% on strong earnings and raised guidance, impacting healthcare sector sentiment. - Charles River Laboratories (CRL) jumped 11% after beating Q2 estimates and increasing its EPS outlook.
Based on reporting from yahoo-sector-etfs.
Healthcare stocks advanced late Wednesday afternoon, led by notable gains in Eli Lilly and Charles River Laboratories. The NYSE Healthcare Index and the Health Care Select Sector SPDR Fund (XLV) both rose 1.2%, reflecting broad sector strength.
Market context for this story
As of: Regular HoursLoading quotes…
Informational only — not investment advice. Full markets →
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
$XLVHealth Care Select Sector
TradingView
Live chart & market data via TradingView · Delayed or exchange real-time per TradingView data agreements · Not investment advice
$CRLCharles River Laboratories
TradingView
Live chart & market data via TradingView · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView charts — search any symbol in the widget. Confirm on /markets/XLV and related $CRL, $BMY, $AZN. Not investment advice.
Healthcare stocks climbed late Wednesday afternoon, with the NYSE Healthcare Index and the Health Care Select Sector SPDR ETF (XLV) each adding 1.2%. The iShares Biotechnology ETF (IBB) also saw gains, increasing 0.5%.
In corporate news, Eli Lilly (LLY) shares rose 4.7% after reporting higher Q2 non-GAAP earnings and revenue, along with an increased 2026 sales outlook. CVS Health (CVS) shares declined 3.8% despite announcing a revamped direct-to-consumer weight management program in collaboration with Lilly.
Novo Nordisk (NVO) shares gained 0.6% following a preliminary injunction in the Netherlands related to a patent infringement case. AstraZeneca (AZN) rose 3.5% and Bristol Myers Squibb (BMY) fell 3.2% amid reports they are not engaged in merger discussions.
Charles River Laboratories ($CRL+WL) shares jumped 11% after reporting fiscal Q2 non-GAAP earnings and sales above expectations and raising its 2026 non-GAAP EPS guidance.
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
Based on reporting from yahoo-sector-etfs.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).